+ All Categories
Home > Documents > Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Date post: 23-Jan-2016
Category:
Upload: nara
View: 47 times
Download: 0 times
Share this document with a friend
Description:
Data Sharing in Health and Science: Something to Fear or Embrace? April 8 2014 Centre for Medical Ethics and Law University of Hong Kong. Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics Associate Dean for Bioethics, IU School of Medicine Professor of Bioethics. - PowerPoint PPT Presentation
Popular Tags:
34
Data Sharing in Health and Science: Something to Fear or Embrace? April 8 2014 Centre for Medical Ethics and Law University of Hong Kong Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics Associate Dean for Bioethics, IU School of Medicine Professor of Bioethics
Transcript
Page 1: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Data Sharing in Health and Science:Something to Fear or Embrace?

April 8 2014Centre for Medical Ethics and Law

University of Hong Kong

Eric M. Meslin, Ph.D.Director, Indiana University Center for Bioethics

Associate Dean for Bioethics, IU School of MedicineProfessor of Bioethics

Page 2: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“The more the data banks record about each one of us, the less we exist.”

Page 3: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“Consumer scores – created by either the government or the private sector – threaten privacy, fairness, and due process because scores, particularly opaque scores with unknown ingredients or factors, can too easily evade the rules established to protect consumers”.

Page 4: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Outline

• Conceptual understanding of data (big and small)

• Data on data sharing • Comment on the value of the fear vs

embrace data sharing dichotomy• Promising approaches for balancing privacy

protection and public health promotion

Page 5: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Support:Collegial and Financial

•UL1RR025761-01/NIH Indiana Clinical and Translational Sciences Institute •Pierre de Fermat Chaire d’Excellence Program, Midi-Pyrénées Regional Council, France •State Grants to Promote Health Information Technology (Health Information Exchange Challenge Program) Award No: 90HT0054/01, CFDA•IU Center for Law, Ethics, and Applied Research in Health Information (CLEAR) which receives funding from the Lilly Endowment, Inc.

• Anne Cambon-Thomsen• Fred Cate• Stan Crosley• Brad Doebbling• Ken Goodman• Jane Kaye• Bartha Knoppers• Kimberly Quaid• Josh Rager• Peter Schwartz• Anantha Shekhar• William Tierney

Page 6: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“Big data refers to datasets whose size is beyond the ability of typical database software tools to capture, store, manage and analyze.”“If US healthcare were to use big data creatively and effectively to drive efficiency and quality, the sector could create more than $300 billion in value every year.”

Page 7: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“… the products of research [or observation], be they the mathematical calculations or findings of a quantitative intervention (e.g., the number count of patients who responded to a therapy, or the percentage of tumour reduction achieved by chemotherapy); or the experiential findings of qualitative research (e.g., the descriptions that families give of how they cope with loss).”

Page 8: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Data ~ Information ~ Knowledge

Page 9: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 10: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

X 54

Page 11: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 12: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

4.7 GB

Page 13: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 14: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

• Hospital• Physician

Offices• Insurance Co.• Hospital Billing• Physician Billing• WebMD• Facebook• YouTube• Gmail• PatientsLikeMe• Pharmacy• Google• CancerNet

Page 15: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 16: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 17: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 18: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Physicians and Nurses—Pediatric Biobanking•MD and RN attitudes toward pediatric biobanks are similar.•Broad support for a pediatric biobank from HCP, including support for unspecified use of samples.

Denne, Wolf , Meslin et al (2008)

Women and Pregnant Mothers• 77% felt predictive health

research was worthwhile• Most supported consent for

future use

Haas, Renbarger, Meslin, Drabiak, Flockhart (2006)

IU Cancer Patients• ~85% agreed that stored tissue

could be used in unspecified future research

• 60-70% would not require re-contact each time tissues were used

Helft , Champion, Eckles, Johnson, Meslin, (2007)

Page 19: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“When people in the general community were asked if they approved of their information being used in this way, they were found to be not only supportive of it, but they questioned why it was not already being done.”

Stanley and Meslin (2007)

Page 20: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Five Big Questions

1. Who Wants Access?• public, private researchers/institutions

2. What Specifically Do They Want? • sensitive, identifiable, de-identified,

linked3. When Do They Want It (And For How Long)?4. Where Will The Data Be Used?

• domestic or offshore5. Why Do They Want It?

• research, treatment, product development

Page 21: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

What About Researchers?

Page 22: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

• Reorganization of data files for harmonization• Burdensome data retrieval• Inadequate technical resources• Lack of human resources• Lack of financial resources• Difficult to obtain permission from home

institute (infrequent)• Difficult to obtain permission from ethics

board• Tight deadline for participation • Unclear data sharing policy• Confidentiality of data (not frequent)• Privacy of the data (not frequent)• Data used for purposes not compliant with

the original consent• Data shared for other research purposes • Data used for commercial purposes• Contribution would not be recognized• Data already been used for same research

purposes• Deadlines were too tight• The data that could have been used became

available too late• No human resources available to submit data• Project was not within the scope of own

research• Effort required to actually produce materials

or information

• No incentives to deposit such data• Having no place to put data• Lack of standards• Sponsor doesn’t require it• No data management plan required by funder• Long term data storage process dissatisfcation• Dissatifacation with metadata tools • Long term data storage support dissatisfication• Data may be misinterpreted due to complexity of and poor

quality of data • Don’t use metadata standards• Participation in another consortium• Not legally possible• Seen as unnecessary and time consuming• Insufficient time• Lack of funding• too busy, too much work• no longer had jurisdiction over data as had changed institutions

(institution stated: too long to organize and annotate and too much work)

• forbidden to pass on to third parties• Having received a high number of requests• Trainees in high-competition labs more likely to have been

denied access• Perceived competition in group led to withholding info from

others

Page 23: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Reasons, Factors and Considerations Researchers

Give for Not Sharing Data

• Policies or Rules Prevent Data Sharing• Logistical Arrangements Inhibit Data

Sharing• Personal, Professional Reasons Disincline

Data Sharing

Page 24: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Policies/Rules Prevent Data Sharing

• Collaboration agreements with industry

• Conditions placed on grant awards or contracts

• Regulatory policies for protecting privacy

Page 25: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Logistical Pragmatic Arrangements Inhibit Data Sharing

• Insufficient protected time or human resources

• Insufficient infrastructure for physical transfer

• Inconsistent standards

Page 26: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Personal/Professional Reasons Disincline Data Sharing

• Receiving credit in publications, discoveries

• Fear of losing scientific edge or advantage

• Worries about misuse of “their” data

• Concern for protection of privacy/welfare of others

Page 27: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

On the other hand...inconsistency leads to fear

• Researchers are interested in data sharing and recognize its importance and benefits

• Truth value of reasons given can be questioned

• An unquestioned belief in the power of technology to solve problems

Page 28: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 29: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“Too little privacy can endanger democracy. But so too can too much privacy”

Page 30: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

“Finally, at some point most patients should have an opportunity to review their medical record and to make informed choices about whether their entire record is to be available to everyone or whether certain portions of the record are privileged and should only be accessible to their principal physician or to others explicitly designated by the patient.”

Page 31: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics
Page 32: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Good Governance:Public Engagement

• Simple engagement Provide information to public

prior to consent

• Moderate engagement Involve the public in discussions

prior to developing a bank about policy

• Complex engagement Public given authority to develop

priorities for bank

Page 33: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

Shared norms and Policy Platforms

• Focused on real problem• Built from an evidence

base• Involve public and

experts• Grounded in good science

and good ethics

Page 34: Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics

410 West 10th Street, Suite 3100Indianapolis, IndianaUSA 46202-3002Tel: (317) 278-4034Fax: (317) 278-4050www.bioethics.iu.edu


Recommended